Michael C. Fiore

Michael C. Fiore

Auto-generated profile, based on publicly available information

Michael C. Fiore

Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2016 in JAMA
Verified
Journal Article
Open access
PDF file
TBTimothy B. Baker
Timothy B. Baker
MPMegan E. Piper
Megan E. Piper
JSJames Stein
James Stein
SSStevens S. Smith
Stevens S. Smith
DBDaniel Bolt
Daniel Bolt
MFMichael C. Fiore
Michael C. Fiore
Due to the profound health effects of tobacco smoking,1 it is important to identify treatments that increase rates of long-term smoking abstinence. Research on pharmacotherapies for cessation is especially important because pharmacotherapies can be disseminated broadly via health care systems.

29 September 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
MFMichael C. Fiore
Michael C. Fiore
TBTimothy B. Baker
Timothy B. Baker
Strategies to facilitate smoking cessation are reviewed, including documentation of smoking status for all patients, regular assessment of readiness to quit, counseling, and medications. Use of these strategies is guided by a patient's willingness and by coexisting conditions.

1 January 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
TMTim McAfee
Tim McAfee
SBStephen Babb
Stephen Babb
SMSimon McNabb
Simon McNabb
MFMichael C. Fiore
Michael C. Fiore
In its review of tobacco-dependence treatments, the 2008 clinical practice guideline of the U.S. Public Health Service concluded, “Indeed, it is difficult to identify any other condition that presents such a mix of lethality, prevalence, and neglect, despite effective and readily available interventions.”1 The low utilization of clinical cessation interventions by smokers and physicians alike is partly attributable to inadequate insurance coverage1,2: many health insurers still fail to cover the evidence-based counseling and medication treatments recommended in the 2008 guideline.2 Even when these treatments are covered, barriers to utilization such as copayments and prior-authorization requirements make obtaining them costly and inconvenient.2 Furthermore, complex, unclear, and variable tobacco-cessation coverage can be confusing for both physicians and patients, making it harder for physicians to help patients quit smoking.2

1 January 2003 in Journal of Abnormal Psychology
Verified
Journal Article
Closed access
TPThomas M. Piasecki
Thomas M. Piasecki
DJDouglas E. Jorenby
Douglas E. Jorenby
SSStevens S. Smith
Stevens S. Smith
MFMichael C. Fiore
Michael C. Fiore
TBTimothy B. Baker
Timothy B. Baker
In this article, the authors assessed whether continuously scaled symptom parameters derived from growth models (T. M. Piasecki et al., 2003) are linked to smoking at long-term follow-up by using data from a large-scale clinical trial (N = 893). Results revealed that higher withdrawal intercepts, positive linear slopes, and greater volatility were all positively associated with relapse, and cigarette coefficients (indicating smoking-induced withdrawal reduction) were negatively related to relapse. In models keyed around the first lapse to smoking, those destined to lapse reported more severe withdrawal during abstinence, and withdrawal patterns discriminated groups defined according to lapse duration. The findings complement earlier heterogeneity studies in implicating the pattern of changing withdrawal symptoms over time as a factor strongly associated with smoking relapse.

4 September 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MFMichael C. Fiore
Michael C. Fiore
HDHeather D’aNgelo
Heather D’aNgelo
TBTimothy Baker
Timothy Baker
For half a century, the practice of evidence-based oncology care has depended on 3 primary intervention strategies: surgery, radiotherapy, and chemotherapy. The

23 January 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MFMichael C. Fiore
Michael C. Fiore
SSSteven A. Schroeder
Steven A. Schroeder
TBTimothy B. Baker
Timothy B. Baker
January 2014 marks the 50th anniversary of the landmark Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service — an important moment to take stock of efforts to eliminate the harms of tobacco use. Smoking rates in the United States have decreased dramatically over the past 50 years. The prevalence of smoking among adults fell from about 43% in 1965 to about 18% in 2012, meaningfully reducing rates of smoking-caused disease and death (see maps ). These outcomes are a testament to the policy, legal, and clinical strategies begun 50 years ago that have reduced tobacco use and mitigated its harms.